BIOMAT Database Logo BIOMAT Database Logo

Chromosome aberrations in lymphocytes from women irradiated for benign and malignant gynecological disease. 1994

R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
Radiation Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Excess leukemias have occurred after partial-body radiotherapy for cervical cancer and benign gynecological disease (BGD). However, the level of risk is nearly the same in both groups, about twofold, despite a tenfold difference in average dose to active bone marrow (8 Gy vs 0.7 Gy, respectively). High-dose cell killing has been postulated as one explanation for this apparent inconsistency. To examine whether chromosome aberration rates observed in lymphocytes many years after exposure might serve as population markers of cancer risk, blood samples were taken from 60 women treated for BGD (34 with radiation) and cytogenetic data compared with previous results from 96 women irradiated for cervical cancer. Remarkably, the rate of stable aberrations, which reflects nonlethal damage in surviving stem cells, was only slightly higher among the cancer patients. Thus the lower-dose regimens to treat benign disorders resulted in much higher aberration yields per unit dose than those for cervical cancer. Assuming that the fraction of cytogenetically aberrant stem cells that survive radiotherapy contributes to the leukemogenic process, these data are then consistent with the epidemiological observations of comparable overall leukemia risks seen in these two irradiated populations. Accordingly, for patient populations given partial-body radiotherapy, stable aberrations at a long time after exposure appear to serve as biomarkers of effective risk rather than as biomarkers of radiation dose received.

UI MeSH Term Description Entries
D007953 Leukemia, Radiation-Induced Leukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION. Radiation-Induced Leukemia,Leukemia, Radiation Induced,Leukemias, Radiation-Induced,Radiation Induced Leukemia,Radiation-Induced Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females

Related Publications

R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
Chromosome aberrations in in vitro irradiated lymphocytes from human cord blood.
February 1979, Experientia,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes.
December 1976, Mutation research,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
[Evolution of chromosome aberrations in lymphocytes from pigs irradiated in vivo with cobalt-60].
March 1972, Annales de genetique,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
Chromosome aberrations in mixed cultures of in vitro irradiated and unirradiated human lymphocytes.
February 1988, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
[The analysis of genomic mutations and structural chromosome aberrations in irradiated human lymphocytes].
January 2008, Radiatsionnaia biologiia, radioecologiia,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
Chromosome aberrations in patients irradiated for pelvic tumours.
December 1987, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
[Chromosome aberrations in irradiated human subjects].
October 1966, Jinrui idengaku zasshi. The Japanese journal of human genetics,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
CHROMOSOME ABERRATIONS IN IRRADIATED HUMAN SUBJECTS.
March 1964, Annals of the New York Academy of Sciences,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
Elimination of chromosome aberrations from human lymphocytes.
May 1966, Blood,
R A Kleinerman, and L G Littlefield, and R E Tarone, and A M Sayer, and D L Cookfair, and J Wactawski-Wende, and P D Inskip, and A Block, and K H Ramesh, and J D Boice
Chromosome aberrations in peripheral lymphocytes of patients irradiated with 15-MeV-photons for Morbus Hodgkin.
July 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
Copied contents to your clipboard!